Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts

Human Reproduction
Hideki KonishiY Hiramatsu

Abstract

We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or that smoke, on human trophoblasts. First trimester human chorionic villi of 6-10 week gestation were obtained. Expression and localization of the receptor for AGEs (RAGE) was examined by western blotting and immunohistochemistry. Macrophage inflammatory protein (MIP)-1alpha and MIP-1beta, regulated upon activation, normal T-cell expressed and secreted (RANTES), and human chorionic gonadotropin (hCG) in culture medium were measured by ELISA. Trophoblastic apoptosis was evaluated by the Hoechst 33258 staining and the in situ nick end labeling technique. RAGE was localized in trophoblasts. AGEs significantly stimulated secretion of both MIP-1alpha and MIP-1beta from trophoblasts in a time- and dose-dependent manner. AGEs significantly induced apoptosis and reduced secretion of hCG. Increased secretions of MIP-1alpha and MIP-1beta by AGEs were significantly suppressed by inhibitors of nitric oxide synthase (NOS) or nafamostat mesilate, a synthetic serine protease inhibitor and a suppressor of transcription factor, NF-kappaB activation. These agents also suppressed the effects of AGEs on ...Continue Reading

Citations

Jun 17, 2011·Antioxidants & Redox Signaling·Martha LappasAlicia Jawerbaum
Nov 22, 2013·Human Reproduction·Mette Haug StensenPeter Fedorcsak
Apr 24, 2012·Human Reproduction Update·Alison E WallaceJudith E Cartwright
May 15, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Roberto RomeroSonia S Hassan
Jun 26, 2013·Free Radical Research·L Guedes-MartinsH Almeida
Sep 19, 2015·Molecular Immunology·Angela JeanesTrent M Woodruff
Mar 11, 2016·American Journal of Reproductive Immunology : AJRI·Koumei ShirasunaTakehito Kuwayama
Jul 1, 2009·Journal of Anatomy·Lopa LeachFlavia Sciota
Jan 16, 2009·American Journal of Reproductive Immunology : AJRI·Magdalena Pertyńska-MarczewskaJan Wilczyński
Mar 14, 2014·Redox Biology·Christiane OttAndreas Simm
Oct 15, 2013·Journal of Reproductive Immunology·Anne Cathrine StaffChristopher W G Redman
Mar 13, 2009·Journal of Perinatology : Official Journal of the California Perinatal Association·L GuoshengL Xianqiong
Apr 25, 2018·Hypertension·Katherine R MillenIrina A Buhimschi
Nov 30, 2018·Canadian Journal of Physiology and Pharmacology·Marie-Eve BrienSylvie Girard
Jul 26, 2019·Oxidative Medicine and Cellular Longevity·Sara MendesElisabete Silva
Jul 8, 2020·Human & Experimental Toxicology·X-H WangL-Y Meng
Mar 14, 2020·Archives of Pathology & Laboratory Medicine·Alan KerbyAlexander E P Heazell
Dec 29, 2020·Archives of Pathology & Laboratory Medicine·Alan KerbyAlexander E P Heazell
Jun 2, 2021·European Journal of Clinical Investigation·Luís F GriloSusana P Pereira
Oct 30, 2007·Archives of Biochemistry and Biophysics·Helan XiaoMingyao Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis